연구동향 분석
박사

Hepatoprotective effects of ursodeoxycholic acid explored via global metabolomics and bile acid profilings

김다정 2020년

논문상세정보
인용/피인용
' Hepatoprotective effects of ursodeoxycholic acid explored via global metabolomics and bile acid profilings' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의료과학 약
  • bile acid profiling
  • hepatoprotectiveeffect
  • metabolomics
  • metagenomics
  • ursodeoxycholic acid
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
402 0

0.0%

' Hepatoprotective effects of ursodeoxycholic acid explored via global metabolomics and bile acid profilings' 의 참고문헌

  • miR-122 -- a key factor and therapeutic target in liver disease
    62 ( 2 ) : p. 448-57 [2015]
  • al. , Absorption and metabolism of caffeic acid and chlorogenic acid in the small intestine of rats
    96 ( 1 ) : p. 39-46 . [2006]
  • Ursodeoxycholic acid in cholestasis : linking action mechanisms to therapeutic applications
    121 ( 12 ) : p. 523-44 . [2011]
  • Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
    62 ( 6 ) : p. 1398-404 [2015]
  • Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
    23 ( 15 ) : p. 2771-2784 [2017]
  • Transport and metabolism of ferulic acid through the colonic epithelium .
    36 ( 1 ) : p. 190-197 . [2008]
  • Therapeutic potential of the endocrine fibroblast growth factors FGF19 , FGF21 and FGF23
    15 ( 1 ) : p. 51-69 . [2016]
  • The solute carrier family SLC10 : more than a family of bile acid transporters regarding function and phylogenetic relationships
    372 ( 6 ) : p. 413-431 [2006]
  • The aging liver . Drug clearance and an oxygen diffusion barrier hypothesis
    34 ( 5 ) : p. 359-73 . [1998]
  • Role of plasma amino acids and gaba in alcoholic and non-alcoholic fatty liver disease-a pilot study
    25 ( 1 ) : p. 37-42 [2010]
  • Review article : mechanisms of action and therapeutic applications of ursodeoxycholic acid inChronic liver diseases
    13 ( 8 ) : p. 979-96 [1999]
  • Recent Advances in Understanding of NASH : MicroRNAs as Both Biochemical Markers and Players
    2 ( 3 ) : p. 109-115 [2014]
  • Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis
    4 ( 12 ) : p. 1537-43 [2006]
  • Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosingCholangitis
    60 ( 3 ) : p. 931-40 . [2014]
  • Polyphenols : do they play a role in the prevention of human pathologies ?
    56 ( 4 ) : p. 200-207 . [2002]
  • Plasma phospholipids and fatty acidComposition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects
    6 ( 7 ) : p. e220 [2016]
  • Plasma metabolomic profile in nonalcoholic fatty liver disease
    60 ( 3 ) : p. 404-13 [2011]
  • Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside
    55 ( 3 ) : p. 471-478 . [2006]
  • Phosphatidylcholine homeostasis and liver failure
    280 ( 45 ) : p. 37798-802 . [2005]
  • Outer membrane vesicles of a human commensal mediate immune regulation and disease protection .
    12 ( 4 ) : p. 509-20 . [2012]
  • New-found link between microbiota and obesity
    6 ( 4 ) : p. 110-9 [2015]
  • New paradigms in the treatment of hepatic cholestasis : from UDCA to FXR , PXR and beyond
    62 ( 1 Suppl ) : p. S25-37 . [2015]
  • Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
    4 : p. 2384 . [2013]
  • Microbial metabolism of dietary components to bioactive metabolites : opportunities for new therapeutic interventions
    8 ( 1 ) : p. 46 [2016]
  • Metabolomic analysis of human cirrhosis , hepatocellular carcinoma , non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
    9 ( 3 ) : p. 158-73 . [2016]
  • Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer 's Disease
    7 ( 2 ) [2017]
  • Liver disease associated with canalicular transport defects : current and future therapies
    52 ( 2 ) : p. 258-71 . [2010]
  • Isomer-dependent metabolic effects of conjugated linoleic acid : insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha
    51 ( 7 ) : p. 2037-44 . [2002]
  • Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans .
    71 ( 10 ) : p. 6077-85 [2005]
  • Interaction between Phenolics and Gut Microbiota : Role in Human Health
    57 ( 15 ) : p. 6485-6501 [2009]
  • Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity
    62 ( 6 ) : p. 1234-1236 [2015]
  • Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults
    80 ( 3 ) : p. 692-699 [2004]
  • Inflammatory bowel disease alters intestinal bile acid transporter expression
    42 ( 9 ) : p. 1423-31 [2014]
  • Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach
    7 ( 1 ) : p. 11433 [2017]
  • High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis : a double-blind , randomized , placebo-controlled trial
    52 ( 2 ) : p. 472-9 . [2010]
  • Gut microbe-derived extracellular vesicles induce insulin resistance , thereby impairing glucose metabolism in skeletal muscle
    5 : p. 15878 [2015]
  • Future trends in the treatment of non-alcoholic steatohepatitis
    134 : p. 289-298 . [2018]
  • Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver
    134 ( 11 ) : p. 3083-3088 . [2004]
  • Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice
    152 ( 6 ) : p. 1462-1476 e10 [2017]
  • Exploration of Biomarkers for Amoxicillin/Clavulanate-Induced Liver Injury : Multi-Omics Approaches
    10 ( 3 ) : p. 163-171 . [2017]
  • Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis .
    13 ( 3 ) : p. 259-68 . [2010]
  • Energy metabolism in the liver
    4 ( 1 ) : p. 177-97 . [2014]
  • Effect of ursodeoxycholic acid on glycemic markers : A systematic review and meta-analysis of clinical trials
    135 : p. 144-149 [2018]
  • Effect of Vitamin E With Therapeutic Iron Supplementation on Iron Repletion and Gut Microbiome in US Iron Deficient Infants and Toddlers
    63 ( 3 ) : p. 379-85 [2016]
  • Early postoperative change of plasma levels of amino acids in neonates with perforative peritonitis and its prognostic significance
    30 ( 4 ) : p. 559-62 [1995]
  • Chlorogenic acid and caffeic acid are absorbed in humans .
    131 ( 1 ) : p. 66-71 . [2001]
  • Chemistry , natural sources , dietary intake and pharmacokinetic properties of ferulic acid : A review
    109 ( 4 ) : p. 691-702 . [2008]
  • Apical sodium dependent bile acid transporter ( ASBT , SLC10A2 ) : a potential prodrug target
    3 ( 3 ) : p. 223-30 . [2006]
  • Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells
    53 ( 8 ) : p. 4396-406 [2012]
  • Analysis and update of the human solute carrier ( SLC ) gene superfamily
    3 ( 2 ) : p. 195-206 . [2009]
  • An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
    22 ( 3 ) : p. 192-7 [2016]
  • Alcohol-induced oxidative stress in the liver : in vivo measurements
    447 : p. 185-97 [2008]
  • Aging and liver disease
    31 ( 3 ) : p. 184-91 . [2015]
  • Age-related increase in alanine aminotransferase correlates with elevated levels of plasma amino acids , decanoylcarnitine , Lp-PLA2 Activity , oxidative stress , and arterial stiffness
    13 ( 7 ) : p. 3467-75 . [2014]
  • Age-related changes in liver structure and function : Implications for disease ? Exp Gerontol
    40 ( 8-9 ) : p. 650-9 [2005]
  • A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites
    551 ( 7682 ) : p. 648-652 [2017]
  • A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis .
    375 ( 7 ) : p. 631-43 . [2016]
  • A Metagenomic Analysis Provides a CultureIndependent Pathogen Detection for Atopic Dermatitis
    9 ( 5 ) : p. 453-461 . [2017]
  • 21. Paumgartner, G. and U. Beuers, Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisited. Hepatology, 2002. 36(3): p. 525-531.
  • 19. Haedrich, M. and J.F. Dufour, UDCA for NASH: end of the story? J Hepatol, 2011. 54(5): p. 856-8.
  • 16S rRNA gene-based metagenomic analysis reveals differences in bacteria-derived extracellular vesicles in the urine of pregnant and non-pregnant women
    48 : p. e208 [2016]
  • 10. Johnson, C.H., J. Ivanisevic, and G. Siuzdak, Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol, 2016. 17(7): p. 451-9.